Medication-related osteonecrosis of the jaw: bibliometric analysis from 2003 to 2023

dc.authorid0000-0002-8511-6349
dc.contributor.authorBayram, Ferit
dc.contributor.authorKılıç, Sabire Senem
dc.contributor.authorAydın, Volkan
dc.contributor.authorAkıcı, Ahmet
dc.contributor.authorUlucan, Korkut
dc.contributor.authorAkkoç, Tunç
dc.date.accessioned2024-08-28T11:28:44Z
dc.date.available2024-08-28T11:28:44Z
dc.date.issued2025
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Farmakoloji Ana Bilim Dalı
dc.description.abstractMedication-related osteonecrosis of the jaw (MRONJ) is a serious condition associated with the use of antiresorptive and antiangiogenic medications. Despite extensive research, the pathophysiology of MRONJ remains poorly understood. Bibliometric analysis provides insights into the academic impact of research, helping identify influential works and emerging trends in this field. This study employed a bibliometric analysis of MRONJ publications indexed in Web of Science from 2003 to 2023. The analysis included English-language articles and utilized the VOSviewer, R Studio Bibliometrix package, and Graphpad to evaluate citation counts, publication trends, and collaboration patterns. This study unveils the current situation of the MRONJ research, addressing well-recognized safety issues of antiresorptive and antiangiogenic agents. Our findings may suggest that the overall trend of the MRONJ research continues to evolve and is not likely to reach its peak or plateau yet. We believe that our work will help to identify gaps in the literature and future research directions, contributing to a better understanding of MRONJ management.
dc.identifier.citationBayram, F., Kılıç, S. S., Aydın, V., Akıcı, A., Ulucan, K. ve Akkoç, T. (2025). Medication-related osteonecrosis of the jaw: bibliometric analysis from 2003 to 2023. Advances in Experimental Medicine and Biology içinde 1474, (119-130. ss.), Springer. http://dx.doi.org/10.1007/5584_2024_818
dc.identifier.doi10.1007/5584_2024_818
dc.identifier.endpage130
dc.identifier.issn0065-2598
dc.identifier.pmid39075305
dc.identifier.scopus2-s2.0-85211707828
dc.identifier.scopusqualityQ1
dc.identifier.startpage119
dc.identifier.urihttp://dx.doi.org/10.1007/5584_2024_818
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12791
dc.identifier.volume1474
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.institutionauthorAydın, Volkan
dc.language.isoen
dc.relation.ispartofAdvances in Experimental Medicine and Biology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMedication-Related Osteonecrosis of The Jaw (MRONJ)
dc.subjectAntiresorptive Medications
dc.subjectAntiresorptive Drugs
dc.subjectBibliometrics
dc.subjectMRONJ
dc.subjectOsteonecrosis of The Jaw
dc.titleMedication-related osteonecrosis of the jaw: bibliometric analysis from 2003 to 2023
dc.typeKitap Bölümü

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: